Stock Events

Stock Events

Aeglea BioTherapeutics (AGLE) Q3 2023 Earnings

9NovConfirmed

Q4 2022

Q1 2023

Q2 2023

Q3 2023

-9.34

-6.28

-3.21

-0.15

Details

Expected EPS

-0.84

Actual EPS

-9.34

Surprise EPS

-8.5

Surprise Percent

+1,011.9%

Description

Aeglea BioTherapeutics (AGLE) has reported earnings of -9.34 per share for Q3 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.